Birdwatch Archive

Birdwatch Note

2023-05-16 20:40:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Study says "The relevance of these potential cross-reactivities for the clinical course of infection and immunological parameters is yet to be investigated in detail" Studies have found pre-existing immunity to common coronaviruses doesn't confer cross-protection for COVID-19 https://www.frontiersin.org/articles/10.3389/fimmu.2022.790334/full https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.13.2001782

Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1658562127186087948

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1658573275188940823
  • noteId - 1658573275188940823
  • participantId -
  • noteAuthorParticipantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Participant Details
  • createdAtMillis - 1684269658264
  • tweetId - 1658562127186087948
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Study says "The relevance of these potential cross-reactivities for the clinical course of infection and immunological parameters is yet to be investigated in detail" Studies have found pre-existing immunity to common coronaviruses doesn't confer cross-protection for COVID-19 https://www.frontiersin.org/articles/10.3389/fimmu.2022.790334/full https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.13.2001782

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-05-16 20:40:58 UTC
(1684269658264)
1969-12-31 23:59:59 UTC
(-1)
2023-05-17 02:21:24 UTC
(1684290084375)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)
2023-05-16 20:40:58 UTC
(1684269658264)
1969-12-31 23:59:59 UTC
(-1)
2023-05-31 02:39:52 UTC
(1685500792003)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-16 18:52:47 -0500 Rating Details
2023-05-16 18:08:37 -0500 Rating Details
2023-05-16 17:54:58 -0500 Rating Details
2023-05-16 17:25:41 -0500 Rating Details
2023-05-16 17:13:41 -0500 Rating Details
2023-05-16 17:09:42 -0500 Rating Details
2023-05-16 17:04:26 -0500 Rating Details
2023-05-16 17:00:53 -0500 Rating Details
2023-05-16 16:55:48 -0500 Rating Details
2023-05-16 16:54:47 -0500 Rating Details
2023-05-16 16:53:03 -0500 Rating Details
2023-05-16 16:52:18 -0500 Rating Details
2023-05-16 16:40:33 -0500 Rating Details
2023-05-16 16:34:34 -0500 Rating Details
2023-05-16 16:33:36 -0500 Rating Details
2023-05-16 16:30:20 -0500 Rating Details
2023-05-16 16:21:12 -0500 Rating Details
2023-05-16 16:20:17 -0500 Rating Details
2023-05-16 16:08:29 -0500 Rating Details
2023-05-16 16:08:09 -0500 Rating Details
2023-05-16 16:07:29 -0500 Rating Details
2023-05-16 16:06:40 -0500 Rating Details
2023-05-16 16:05:20 -0500 Rating Details
2023-05-16 15:55:31 -0500 Rating Details
2023-05-17 17:16:51 -0500 Rating Details
2023-05-17 16:49:04 -0500 Rating Details
2023-05-17 13:18:18 -0500 Rating Details
2023-05-17 12:48:59 -0500 Rating Details
2023-05-17 10:34:49 -0500 Rating Details
2023-05-17 10:14:22 -0500 Rating Details
2023-05-17 09:03:38 -0500 Rating Details
2023-05-17 09:02:00 -0500 Rating Details
2023-05-17 07:52:38 -0500 Rating Details
2023-05-17 07:20:38 -0500 Rating Details
2023-05-17 06:55:18 -0500 Rating Details
2023-05-17 06:51:12 -0500 Rating Details
2023-05-17 06:36:21 -0500 Rating Details
2023-05-17 06:27:51 -0500 Rating Details
2023-05-17 06:20:25 -0500 Rating Details
2023-05-17 05:21:57 -0500 Rating Details
2023-05-17 04:41:54 -0500 Rating Details
2023-05-17 04:41:11 -0500 Rating Details
2023-05-17 02:58:00 -0500 Rating Details
2023-05-17 02:51:02 -0500 Rating Details
2023-05-17 00:53:09 -0500 Rating Details
2023-05-17 00:00:50 -0500 Rating Details
2023-05-16 22:51:57 -0500 Rating Details
2023-05-16 22:38:26 -0500 Rating Details
2023-05-16 22:36:59 -0500 Rating Details
2023-05-16 22:30:24 -0500 Rating Details
2023-05-16 22:29:43 -0500 Rating Details
2023-05-16 22:11:00 -0500 Rating Details
2023-05-16 21:51:41 -0500 Rating Details
2023-05-16 21:34:22 -0500 Rating Details
2023-05-16 21:09:34 -0500 Rating Details
2023-05-16 21:01:39 -0500 Rating Details
2023-05-16 20:58:14 -0500 Rating Details
2023-05-16 20:33:11 -0500 Rating Details
2023-05-16 20:27:46 -0500 Rating Details
2023-05-16 20:09:55 -0500 Rating Details
2023-05-16 19:42:01 -0500 Rating Details
2023-05-18 00:33:19 -0500 Rating Details
2023-05-17 06:55:18 -0500 Rating Details
2023-05-17 04:41:11 -0500 Rating Details
2023-05-16 16:05:20 -0500 Rating Details
2023-05-16 20:33:11 -0500 Rating Details
2023-05-17 12:48:59 -0500 Rating Details
2023-05-16 17:09:42 -0500 Rating Details
2023-05-16 17:25:41 -0500 Rating Details
2023-05-16 17:00:53 -0500 Rating Details
2023-05-16 16:06:40 -0500 Rating Details
2023-05-17 06:51:12 -0500 Rating Details
2023-05-16 20:58:14 -0500 Rating Details
2023-05-17 02:51:02 -0500 Rating Details
2023-05-16 22:30:24 -0500 Rating Details
2023-05-18 00:33:19 -0500 Rating Details
2023-05-17 13:18:18 -0500 Rating Details
2023-05-17 07:52:38 -0500 Rating Details
2023-05-16 22:51:57 -0500 Rating Details
2023-05-17 10:14:22 -0500 Rating Details
2023-05-17 17:16:51 -0500 Rating Details
2023-05-16 22:29:43 -0500 Rating Details
2023-05-16 22:36:59 -0500 Rating Details
2023-05-16 16:54:47 -0500 Rating Details
2023-05-17 06:20:25 -0500 Rating Details
2023-05-16 21:01:39 -0500 Rating Details
2023-05-17 00:00:50 -0500 Rating Details
2023-05-16 16:34:34 -0500 Rating Details
2023-05-17 09:02:00 -0500 Rating Details
2023-05-17 09:03:38 -0500 Rating Details
2023-05-16 20:27:46 -0500 Rating Details
2023-05-16 21:34:22 -0500 Rating Details
2023-05-16 18:52:47 -0500 Rating Details
2023-05-16 17:54:58 -0500 Rating Details
2023-05-16 22:11:00 -0500 Rating Details
2023-05-16 16:33:36 -0500 Rating Details
2023-05-16 18:08:37 -0500 Rating Details
2023-05-16 17:13:41 -0500 Rating Details
2023-05-16 16:53:03 -0500 Rating Details
2023-05-17 07:20:38 -0500 Rating Details
2023-05-17 02:58:00 -0500 Rating Details
2023-05-16 15:55:31 -0500 Rating Details
2023-05-16 19:42:01 -0500 Rating Details
2023-05-16 16:30:20 -0500 Rating Details
2023-05-17 10:34:49 -0500 Rating Details
2023-05-16 21:51:41 -0500 Rating Details
2023-05-16 16:40:33 -0500 Rating Details
2023-05-16 16:08:09 -0500 Rating Details
2023-05-16 22:38:26 -0500 Rating Details
2023-05-16 16:21:12 -0500 Rating Details
2023-05-17 00:53:09 -0500 Rating Details
2023-05-16 16:55:48 -0500 Rating Details
2023-05-16 16:08:29 -0500 Rating Details
2023-05-17 06:27:51 -0500 Rating Details
2023-05-16 21:09:34 -0500 Rating Details
2023-05-16 16:52:18 -0500 Rating Details
2023-05-16 16:07:29 -0500 Rating Details
2023-05-16 17:04:26 -0500 Rating Details
2023-05-17 05:21:57 -0500 Rating Details
2023-05-17 16:49:04 -0500 Rating Details
2023-05-17 04:41:54 -0500 Rating Details
2023-05-16 16:20:17 -0500 Rating Details
2023-05-16 20:09:55 -0500 Rating Details
2023-05-17 06:36:21 -0500 Rating Details